Patients were distributed into subgroups according to the method of treatment as follows : group 1 : n = 57 , trospium 30 mg/day + solifenacin 10 mg/day ; group 2 : n = 61 , trospium 15 mg/day + solifenacin 5 mg/day ; group 3 : n = 59 , placebo .